Figure 1From: Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparumDot plots of IC 50 values in nM for chloroquine (CQ), quinine (QN), pyronaridine (PND), piperaquine (PPQ), mefloquine (MQ), monodesethylamodiaquine (MDAQ), lumefantrine (LMF), dihydroartemisinin (DHA) and artesunate (AS). Each dot represents one isolate.Back to article page